Dr. Mike Sheldon IBX Senior Director, Scientific Affairs is presenting on Advanced Biobanking at the upcoming Sino-American Pharmaceutical Professionals Association Annual Conference.
Advanced Biobanking: Learn How to Harness the Potential of Biobanks from IBX
Saturday, October 2, 2021 / 2:10pm EDT
The 1990’s ushered in the era of “big science” involving large scale studies utilizing biosamples aimed at understanding the etiology and progression of human disease. The NIH National Institute of Mental Health was a leader in recognizing that the data emerging from big science initiatives must be the product of a process that maintains the highest standards of quality in all phases from the recruitment of study participants to the generation and analysis of data. This process, by necessity, includes sample collection logistics, processing, quality control, controlled storage and global distribution to disseminate materials to investigators worldwide. RUCDR Infinite Biologics was established as a biobank built by scientists for scientists with this mission at its core and grew into the world’s largest academically based biobank, maintaining the repositories of several agencies of the NIH and numerous clients. In 2020 RUCDR Infinite Biologics became Infinity BiologiX (IBX). While the name changed, the core mission did not. This presentation will focus on the efforts of IBX to continue to support its expanding commercial and academic client base in the 21st Century by offering a range of cutting-edge services that is constantly evolving with the times.
Connect with Dr. Sheldon on LinkedIn.
Or you can visit the 2021 SAPA Annual Conference website to register.Tags: biobanking, biorepository